293
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of the sequestering properties of yeast cell wall extract and hydrated sodium calcium aluminosilicate in three in vitro models accounting for the animal physiological bioavailability of zearalenone

, , , &
Pages 1641-1650 | Received 01 Nov 2012, Accepted 16 May 2013, Published online: 11 Jul 2013

References

  • Abid-Essefi S, Baudrimont I, Hassen W, Ouanes Z, Mobio ToA, Anane R, Creppy EE, Bacha H. 2003. DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by Vitamin E. Toxicology. 192:237–248.
  • Allen N, Mirocha CJ, Weaver G, Aakhus-Allen S, Bates F. 1981. Effects of dietary zearalenone on finishing broiler chickens and young turkey poults. Poultry Sci. 60:124–131.
  • Awad WA, Aschenbach JR, Setyabudi FMCS, Razzazi-Fazeli E, Bohm J, Zentek J. 2007. In-vitro effects of deoxynivalenol on small intestinal D-glucose uptake and absorption of deoxynivalenol across the isolated jejunal epithelium of laying hens. Poultry Sci. 86:15–20.
  • [Commission] Commission of the European Communities. 2006. 2006/575/EC On the presence of deoxynivalenol, zearalenone, ochratoxin A, T-2 and HT-2 and fumonisins in products intended for animal feeding. Off J Eur Union. L 229:7–9.
  • Diaz DE, Smith TK. 2005. Mycotoxin sequestering agents: practical tools for the neutralization of mycotoxins In: Diaz DE, editor. Mycotoxin blue book. Nottingham: Nottingham University Press; p. 323–339.
  • Dong M, He XJ, Tulayakul P, Li JY, Dong KS, Manabe N, Nakayama H, Kumagai S. 2010. The toxic effects and fate of intravenously administered zearalenone in goats. Toxicon. 55:523–530.
  • FEFANA. 2009. Animal feeding-stuffs – Determination of in-vitro efficacy of mycotoxin inactivators based on adsorption of zearalenone. In: DRAFT Mycotoxin Inactivators: FEFANA Taskforce; p. 10.
  • Firmin S, Gandia P, Morgavi DP, Houin G, Jouany JP, Bertin G, Boudra H. 2010. Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation. Food Addit Contam A. 27:1153–1160.
  • Firmin S, Morgavi DP, Yiannikouris A, Boudra H. 2011. Effectiveness of modified yeast cell wall extracts to reduce aflatoxin B1 absorption in dairy ewes. J Dairy Sci. 94:5611–5619.
  • Freundlich H. 1907. Über die Adsorption in Lösungen [On adsorption in solutions]. Z Phys Chem. 57:385–471.
  • Girish CK, Smith TK, Boermans HJ, Karrow NA. 2008. Effects of feeding blends of grains naturally contaminated with fusarium mycotoxins on performance, hematology, metabolism, and immunocompetence of turkeys. Poultry Sci. 87:421–443.
  • Grant PG, Phillips TD. 1998. Isothermal adsorption of aflatoxin B1 on HSCAS clay. J Agr Food Chem. 46:599–605.
  • Grosse Y, Chekir-Ghedira L, Huc A, Obrecht-Pflumio S, Dirheimer G, Bacha H, Pfohl-Leszkowicz A. 1997. Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett. 114:225–229.
  • Kolosova A, Stroka J. 2011. Substances for reduction of the contamination of feed by mycotoxins: a review. World Mycotoxin J. 4:225–256.
  • Kumar KV, Sivanesan S. 2005. Prediction of optimum sorption isotherm: comparison of linear and non-linear method. J Hazard Mater. 126:198–201.
  • Lemke SL, Ottinger SE, Mayura K, Ake CL, Pimpukdee K, Wang N, Phillips TD. 2001. Development of a multi-tiered approach to the in vitro prescreening of clay-based enterosorbents. Anim Feed Sci Technol. 93:17–29.
  • Malekinejad H, Maas-Bakker R, Fink-Gremmels J. 2006. Species differences in the hepatic biotransformation of zearalenone. Vet J. 172:96–102.
  • Marin DE, Taranu I, Burlacu R, Manda G, Motiu M, Neagoe I, Dragomir C, Stancu M, Calin L. 2011. Effects of zearalenone and its derivatives on porcine immune response. Toxicol In Vitro. 25:1981–1988.
  • Merchant HA, McConnell EL, Liu F, Ramaswamy C, Kulkarni RP, Basit AW, Murdan S. 2011. Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. Eur J Pharm Sci. 42:3–10.
  • Minervini F, Dell”Aquila ME. 2008. Zearalenone and Reproductive Function in Farm Animals. Int J Mol Sci. 9:2570–2584.
  • Ouanes Z, Ayed-Boussema I, Baati T, Creppy EE, Bacha H. 2005. Zearalenone induces chromosome aberrations in mouse bone marrow: preventive effect of beta-estradiol, progesterone and Vitamin E. Mutat Res-Gen Tox En. 565:139–149.
  • Pfeiffer E, Kommer A, Dempe JS, Hildebrand AA, Metzler M. 2011. Absorption and metabolism of the mycotoxin zearalenone and the growth promotor zeranol in Caco-2 cells in-vitro. Mol Nutr Food Res. 55:560–567.
  • Ringot D, Lerzy B, Chaplain K, Bonhoure J-P, Auclair E, Larondelle Y. 2007. In-vitro biosorption of ochratoxin A on the yeast industry by-products: comparison of isotherm models. Bioresour Technol. 98:1812–1821.
  • Schaut A, De Saeger S, Sergent T, Schneider YJ, Larondelle Y, Pussemier L, Van Peteghem C. 2008. Study of the gastrointestinal biotransformation of zearalenone in a Caco-2 cell culture system with liquid chromatographic methods. J Appl Toxicol. 28:966–973.
  • Sergent T, Parys M, Garsou S, Pussemier L, Schneider Y-J LY. 2006. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol Lett. 164:167–176.
  • Sergent T, Ribonnet L, Kolosova A, Garsou S, Schaut A, De Saeger S, Van Peteghem C, Larondelle Y, Pussemier L, Schneider Y-J. 2008. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem Toxicol. 46:813–841.
  • Videmann B, Mazallon M, Prouillac C, Delaforge M, Lecoeur S. 2009. ABCC1, ABCC2 and ABCC3 are implicated in the transepithelial transport of the myco-estrogen zearalenone and its major metabolites. Toxicol Lett. 190:215–223.
  • Whitaker TB. 2003. Standardisation of mycotoxin sampling procedures: an urgent necessity. Food Contr. 14:233–237.
  • Yiannikouris A, André G, Buléon A, Jeminet G, Canet I, François J, Bertin G, Jouany J-P. 2004. Comprehensive conformational study of key interactions involved in zearalenone complexation with beta-D-glucans. Biomacromolecules. 5:2176–2185.
  • Yiannikouris A, André G, Poughon L, Francois J, Dussap C-G, Jeminet G, Bertin G, Jouany J-P. 2006. Chemical and conformational study of the interactions involved in mycotoxin complexation with beta-D-Glucans. Biomacromolecules. 7:1147–1155.
  • Yiannikouris A, François J, Poughon L, Dussap C-G, Bertin G, Jeminet G, Jouany J-P. 2004. Adsorption of Zearalenone by beta-D-glucans in the Saccharomyces cerevisiae cell wall. J Food Prot. 67:1195–1200.
  • Yiannikouris A, François J, Poughon L, Dussap C-G, Jeminet G, Bertin G, Jouany J-P. 2004. Influence of pH on model beta-D-glucans complexation toward zearalenone. J Food Prot. 67:2741–2746.
  • Yiannikouris A, Poughon L, Cameleyre X, Dussap C-G, François J, Bertin G, Jouany J-P. 2003. A novel technique to evaluate interactions between Saccharomyces cerevisiae cell wall and mycotoxins: application to zearalenone. Biotechnol Lett. 25:783–789.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.